Title
Category
Credits
Event date
Cost
  • 1.20 ABNSee more
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
$0.00
This presentation will provide an overview of the history, regulation and marketing of e-cigs, as well as the potential health and safety risks. It will also include counseling points for providers.
  • 1.20 ABNSee more
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
$0.00
This presentation will discuss prevalence, impact and treatment of tobacco use disorder. FDA-Approved medications for smoking cessation will be reviewed, including counseling points and access limitations.
  • 1.20 ABNSee more
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
$0.00
This presentation will provide information about prescription stimulant misuse. Current statistics of misuse will be presented. Vulnerable populations and rationale for misuse will be discussed. Signs and symptoms of misuse and abuse will be presented along with how to manage patients presenting with toxic effects of prescription stimulants.
  • COACH
  • 1.25 ACPE ...See more
$0.00
Correct and complete prescription information is essential to the integrity of the controlled substance database. Incomplete or inaccurate prescription information can result in prescriptions not being transmitted to the controlled substance database, which can cause inaccurate patient records, complications between prescribers and their regulatory boards, and a diminished clinical tool for healthcare providers.
  • 1.20 ABNSee more
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
$0.00
A evaluation of non-traditional, legal, substances that are being misused and abused in the community to achieve legal intoxications.
  • 1.20 ABNSee more
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
$0.00
This presentation will review National and AL data on OUD and use pattern trends. We will discuss risk factors, behavioral clues, and DSM criteria. Epidemiology and prevalence will be discussed. The changing opioid crisis will be discussed with increased emphasis on illicit synthetic opioid use rather than the prescription opioid use driving the current crisis. We will discuss impact of medical cannabis use on patients prescribed opioids for various conditions. 
  • 1.20 ABNSee more
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
$0.00
National and Alabama use patterns & trends will be discussed including data from treatment admissions. Risk factors and DSM criteria along with prevalence and epidemiology will be reviewed. A description of available products and relative potency. We will review heavily utilized alternatives like delta-8 and/or delta-10 along with their legal status. We will review in detail the new AL Medical Cannabis Use from the Alabama Compassion Act in 2021 that will be implemented starting 9/1/22. 
  • COACH
  • 2.40 ABNSee more
  • 2.00 ACPE Pharmacy
  • 2.00 AMA PRA Category 1 Credit™
$0.00
An interactive, 2-hour training session regarding PDMP Usage. Practical application across healthcare professionals with targeted content around common prescribing errors, account maintenance, understanding of prescriber, and patient reports.
  • COACH
  • 8.00 ABNSee more
  • 8.00 ABSWE
  • 8.00 ACPE Pharmacy
05/01/2025
$0.00
This conference aims to improve healthcare professional knowledge, attitudes, and perceived barriers regarding opioid harm reduction strategies amongst vulnerable populations and expand the capacity for harm reduction efforts in underserved communities in the Deep South and nationally.
  • COACH
  • 3.00 ACPE ...See more
  • 3.00 ACPE Technician
  • 3.00 AMA PRA Category 1 Credit™
06/24/2025
$0.00
There are numerous state and federal laws/regulations related to controlled substances. These can be confusing to prescribers and dispensers. This program aims to provide clarification regarding those rules and regulations as well as best practices.

Pages